Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trientine in Wilson Disease Patients Withdrawn From d-Penicillamine
NCT02426905Phase 4Unknown
- Sponsor
- Univar Solutions
- Start
- Jan 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of trientine dihydrochloride in Wilson disease (WD), sponsored by Univar Solutions. Status: unknown.
02
Drugs
trientine dihydrochloride
03
Conditions
Wilson disease (WD)
Beyond the preview
Go deeper on NCT02426905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02426905.